Skip to main content
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 9, 2014

Articles

Favourites:
ADD

The Paths to Neurodegeneration in Genetic Parkinson's Disease
pp. 1485-1512(28)
Author: M.E. Abdel-Salam, Omar

Favourites:
ADD
Favourites:
ADD

Inhibition of Opioid Receptor Mediated G-Protein Activity After Chronic Administration of Kynurenic Acid and its Derivative without Direct Binding to Opioid Receptors
pp. 1520-1529(10)
Authors: Zador, Ferenc; Samavati, Reza; Szlavicz, Eszter; Tuka, Bernadett; Bojnik, Engin; Fulop, Ferenc; Toldi, Jozsef; Vecsei, Laszlo; Borsodi, Anna

Favourites:
ADD

Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
pp. 1530-1541(12)
Authors: Paterniti, Irene; Cordaro, Marika; Campolo, Michela; Siracusa, Rosalba; Cornelius, Carolin; Navarra, Michele; Cuzzocrea, Salvatore; Esposito, Emanuela

Favourites:
ADD

Toll-Like Receptors in Alzheimer’s Disease: A Therapeutic Perspective
pp. 1542-1558(17)
Authors: E. Gambuzza, Maria; Sofo, Vincenza; M. Salmeri, Francesca; Soraci, Luca; Marino, Silvia; Bramanti, Placido

Favourites:
ADD

Modulation of the FGF14:FGF14 Homodimer Interaction Through Short Peptide Fragments
pp. 1559-1570(12)
Authors: Ali, Syed; Shavkunov, Alexander; Panova, Neli; Stoilova-McPhie, Svetla; Laezza, Fernanda

Favourites:
ADD

Is Human Immunodeficiency Virus-Mediated Dementia an Autophagic Defect that Leads to Neurodegeneration?
pp. 1571-1579(9)
Authors: Passeri, Eleonora; Mocchetti, Italo; Moussa, Charbel

Favourites:
ADD

Animal Models for Parkinson's Disease
pp. 1580-1594(15)
Authors: A. Patil, Dilip; A. Patil, Vishal; B. BaRI, Sanjay; J. Surana, Sanjay; O. Patil, Pravin

Favourites:
ADD

Propofol Promotes Blood-Brain Barrier Breakdown and Heat Shock Protein (HSP 72 kd) Activation in the Developing Mouse Brain
pp. 1595-1603(9)
Authors: S. Sharma, Hari; Pontén, Emma; Gordh, Torsten; Eriksson, Per; Fredriksson, Anders; Sharma, Aruna

Favourites:
ADD

Drugs Targeting SNPrs35753505 of the NRG1 Gene May Prevent the Association of Neurological Disorder Schizophrenia in a Pakistani Population
pp. 1604-1614(11)
Authors: Nawaz, Rukhsana; Asif, Huma; Khan, Asifullah; Ishtiaq, Hina; Shad, Fatima; Siddiqui, Sonia

Favourites:
ADD

Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
pp. 1615-1626(12)
Authors: C. Tobon-Velasco, Julio; Cuevas, Elvis; A. Torres-Ramos, Mónica

Favourites:
ADD

The Protective Effects of Crocetin on Aβ1-42-Induced Toxicity in Ht22 Cells
pp. 1627-1632(6)
Authors: Kong, Yan; Kong, Ling-Ping; Luo, Tao; Li, Guang-Wu; Jiang, Wei; Li, Sheng; Zhou, Yue; Wang, Hua-Qiao

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content